123 Results for "

trpc

" in MedChemExpress (MCE) Product Catalog:
Products (123)

123 Results for "trpc" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-N10756
CAS No.: 3118-34-1
Target:  

TRP Channel

Research Areas:  

Neurological Disease

Hyp9 is a transient receptor potential canonical 6 (TRPC6)-specific agonist. Hyp9 can be used for the research of spinal cord injury (SCI) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P2141A
Research Areas:  

Cardiovascular Disease

TRV120027 TFA, a β-arrestin-1-biased agonist of the angiotensin II receptor type 1 (AT1R), engages ?-arrestins while blocking G-protein signaling . TRV120027?TFA induces?acute?catecholamine?secretion?through cation channel subfamily C3 (TRPC3) coupling, promotes the formation of a macromolecular complex composed of AT1R–β-arrestin-1–TRPC3–PLCγ at the plasma membrane. TRV120027 TFA inhibits angiotensin II–mediated vasoconstriction and increases cardiomyocyte contractility. TRV120027 TFA has the potential for the?acute decompensated heart failure (ADHF) treatment .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101795
CAS No.: 4608-49-5
Purity:  99.46%
Larixyl acetate is a potent and selective TRPC6 inhibitor with IC50 values of 0.58 μM and 6.83 μM against hTRPC6-YFP and hTRPC3-YFP, respectively. Larixyl acetate prevents HPV and is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-111098
CAS No.: 924377-85-5
Purity:  99.11%
Target:  

TRP Channel

Research Areas:  

Cardiovascular Disease

GSK1702934A is a selective TRPC3 agonist. GSK1702934A modulates cardiac contractility and f arrhythmogenesis by activation of TRPC3 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-131648
CAS No.: 86390-77-4
Purity:  ≥99.0%
1-Oleoyl-2-acetyl-sn-glycerol is a cell-permeable analog of diacylglycerol (DAG) and can activate Protein kinase C (PKC). 1-Oleoyl-2-acetyl-sn-glycerol can activate the TRPC channels-mediated specific Ca 2+ influx. 1-Oleoyl-2-acetyl-sn-glycerol can stimulate superoxide-generation from human neutrophils. 1-Oleoyl-2-acetyl-sn-glycerol stimulates the formation of phosphatidylinositol 4-phosphate in intact human platelets. 1-Oleoyl-2-acetyl-sn-glycerol can stimulate ascites tumor cell proliferation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-122051
CAS No.: 831234-13-0
Purity:  99.80%
Target:  

TRP Channel

Research Areas:  

Metabolic Disease

AC1903 is a specific and selective inhibitor of TRPC5 and has podocyte-protective properties. AC1903 does no effects on TRPC4 or TRPC6 currents and shows no off-target effects in kinase profiling assays. AC1903 suppresses severe proteinuria and prevents podocyte loss in focal segmental glomerulosclerosis (FSGS) rat model .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133168
CAS No.: 1094250-15-3
Purity:  99.43%
Englerin A is a potent and selective activator of TRPC4 and TRPC5 channels, with EC50s of 11.2 and 7.6 nM, respectively. Englerin A can induce renal carcinoma cells death by elevated Ca 2+ influx and Ca 2+ cell overload .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-30234A
CAS No.: 1163-36-6
Target:  

TRP Channel Apoptosis

Clemizole hydrochloride is an orally active, blood-brain barrier permeable TRPC5 inhibitor, with an IC50 value of 1.05-1.34 μM against mouse TRPC5. Clemizole hydrochloride blocks TRPC1:TRPC5, TRPC3, TRPC4, TRPC6, TRPC7, hERG, hKCNQ1/hKCNE1 and hKv1.5 channels, and activates TRPA1; it modulates 5HT-2B and HTR2A receptors; it inhibits HCV RNA replication, CrtN enzymatic activity, oxidative stress, neuroinflammation, cell apoptosis and bacterial virulence; it maintains blood-brain barrier (BBB) integrity; it enhances DNA repair capacity; it improves cell viability; and it alters cardiac electrophysiological properties. Clemizole hydrochloride can be used in the research of Dravet syndrome, hepatitis C virus infection, Staphylococcus aureus skin infection, Cisplatin (HY-17394)-induced nephrotoxicity, STXBP1-related diseases, traumatic brain injury and xeroderma pigmentosum type C .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12504
CAS No.: 245747-08-4
Purity:  98.47%
Synonyms: N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3-fluoro-4-pyridinecarboxamide
Target:  

CRAC Channel

Research Areas:  

Others

Pyr6 is a selective store operated calcium entry (SOCE) inhibitor with an IC50 of 0.49 μM. Pyr6 displays 37-fold higher potency for RBL SOCE than for TRPC3 ROCE .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-30234
CAS No.: 442-52-4
Target:  

TRP Channel Apoptosis

Clemizole is an orally active, blood-brain barrier permeable TRPC5 inhibitor, with an IC50 value of 1.05-1.34 μM against mouse TRPC5. Clemizole blocks TRPC1:TRPC5, TRPC3, TRPC4, TRPC6, TRPC7, hERG, hKCNQ1/hKCNE1 and hKv1.5 channels, and activates TRPA1; it modulates 5HT-2B and HTR2A receptors; it inhibits HCV RNA replication, CrtN enzymatic activity, oxidative stress, neuroinflammation, cell apoptosis and bacterial virulence; it maintains blood-brain barrier (BBB) integrity; it enhances DNA repair capacity; it improves cell viability; and it alters cardiac electrophysiological properties. Clemizole can be used in the research of Dravet syndrome, hepatitis C virus infection, Staphylococcus aureus skin infection, Cisplatin (HY-17394)-induced nephrotoxicity, STXBP1-related diseases, traumatic brain injury and xeroderma pigmentosum type C .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145150
CAS No.: 2265215-18-5
Purity:  98.97%
Target:  

TRP Channel

Research Areas:  

Metabolic Disease

TRPC5-IN-1 (Compound 6j) is a selective TRPC5 inhibitor with 50.5 % Inhibition for TRPC5 at 3 μM. TRPC5-IN-1 can be used for the research of chronic kidney disease (CKD) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-161766
CAS No.: 2776151-36-9
Target:  

TRP Channel

Research Areas:  

Cancer

L687 is a potent activator of TRPC3/C6/C7 that can induce cellular uptake of oligonucleotides .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101547
CAS No.: 901715-05-7
Purity:  99.71%
Target:  

TRP Channel

Research Areas:  

Cancer

TRPC6-IN-1 is a Transient Receptor Potential Canonical 6 Channel (TRPC6) inhibitor, with an EC50 of 4.66 μM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W017018S4
CAS No.: 2483831-57-6
L-Ornithine-d7 hydrochloride is the d7-labeled L-Ornithine hydrochloride (HY-W017018). L-Ornithine hydrochloride is an orally active CaSR and p38 activator. L-Ornithine hydrochloride inhibits ROS and supports urea cycle function. L-Ornithine hydrochloride can be used to study kidney diseases involving proximal tubular cell damage caused by oxidative stress or crystallopathy, as well as research related to anxiety disorders .
loading...
    loading...
Cat. No.: HY-15699
CAS No.: 1333210-07-3
Purity:  99.82%
Target:  

TRP Channel

Research Areas:  

Neurological Disease

SAR7334 is a potent and specific TRPC6 inhibitor, inhibiting TRPC6 currents with IC50 of 7.9 nM.
loading...
    loading...
Cat. No.: HY-W641445
CAS No.: 15533-81-0
Target:  

TRP Channel

Research Areas:  

Inflammation/Immunology

ELP-004 is a TRPC channel inhibitor and inhibtis TRPC channel-mediated Ca 2+ entry. ELP-004 is an osteoclast inhibitor and inhibits osteoclast differentiation. ELP-004 inhibits basal Ca 2+ and related NFATc1 translocation in inflammatory osteoclastogenesis. ELP-004 reduces bone erosion in a mouse model of rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-133012
CAS No.: 2304549-73-1
Purity:  99.74%
Target:  

TRP Channel

Research Areas:  

Neurological Disease

GFB-8438 is a potent and subtype selective TRPC5 inhibitor, with IC50s of 0.18 and 0.29 μM of hTRPC5 and hTRPC4, respectively. GFB-8438 shows excellent selectivity against TRPC6, other TRP family members, NaV 1.5, as well as limited activity against the hERG channel. GFB-8438 protects mouse podocytes from injury induced by protamine sulfate model .
loading...
    loading...
Cat. No.: HY-138668
CAS No.: 2763378-71-6
Purity:  99.05%
Target:  

TRP Channel

Research Areas:  

Neurological Disease

JW-65 is a selective TRPC3 channel inhibitor with favorable blood-brain barrier penetration. JW-65 directly binds to human TRPC3 protein and modulates calcium signaling to reduce seizure susceptibility. JW-65 reduces seizure incidence, severity, and duration while prolonging seizure latency in multiple seizure models. JW-65 alleviates Aβ‑induced neuronal damage. JW-65 serves as a valuable tool for research on epilepsy, seizure disorders, and Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-116330
CAS No.: 11079-53-1
Hyperforin is a transient receptor canonical 6 (TRPC6) channels activator. Hyperforin modulates Ca 2+ levels by activating Ca 2+-conducting non-selective canonical TRPC6 channels and triggers adipose tissue thermogenesis via the Dlat-AMPK signaling axis to suppress obesity. Hyperforin also shows diverse pharmacological activities including anti-depression, anti-tumor, anti-dementia, anti-diabetes. Hyperforin modulates γδ T cells to secret IL-17α, improves Imiquimod (HY-B0180)-induced psoriasis-like mice model .
loading...
    loading...
Cat. No.: HY-148129
CAS No.: 2311863-36-0
Purity:  99.62%
Synonyms: trpc6-IN-3
Target:  

TRP Channel

Research Areas:  

Cardiovascular Disease

Apecotrep (TRPC6-IN-3) (compound 17) is a potent, orally active transient receptor potential C6 ion channel (TRPC6) inhibitor. Apecotrep modulates not only intracellular calcium concentration, but also membrane potential by modulating the flux of cations including calcium and sodium ions. Apecotrep can be used in research of respiratory system .
loading...
    loading...